DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

Press releases published on October 1, 2026

Oct. 1, 2026

CompoSecure 於倫敦開立新設計中心，以滿足國際對優質金屬卡日益增長的需求

Indeterminate GlobeNewswire

Oct. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

STACK Infrastructure Achieves SBTi Validation of Science-Based Net-Zero Targets

Indeterminate GlobeNewswire

Oct. 1, 2026

Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Oct. 1, 2026

ESCO Completes Acquisition of Megger Group Limited

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier

Indeterminate GlobeNewswire

Oct. 1, 2026

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Indeterminate GlobeNewswire

Oct. 1, 2026

WISeSat.Space Holdings Corp. Announces Closing of Business Combination with Columbus Acquisition Corp.

Indeterminate GlobeNewswire

Oct. 1, 2026

WISeKey’s Redomiciliation from Switzerland to the British Virgin Islands Becomes Legally Effective

Indeterminate GlobeNewswire

Oct. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Digital Realty Schedules Third Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Oct. 1, 2026

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

Indeterminate GlobeNewswire

Oct. 1, 2026

Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®

Indeterminate GlobeNewswire

Oct. 1, 2026

Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma

Indeterminate GlobeNewswire

Oct. 1, 2026

NexusTek Announces a New AI Strategy Assessment to Close the Gap Between AI Ideas and Actionable Investments

Indeterminate GlobeNewswire

Oct. 1, 2026

Tatari Marks 10 Years of TV Innovation and Announces Forward™ 2026 Speaker Lineup

Indeterminate GlobeNewswire

Oct. 1, 2026

Benevity bringt Spenden und ehrenamtliches Engagement mit Benevity für Microsoft Teams direkt in den Arbeitsalltag

Indeterminate GlobeNewswire

Oct. 1, 2026

Benevity lance Benevity pour Microsoft Teams et intègre les dons et le bénévolat au quotidien des entreprises

Indeterminate GlobeNewswire